Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
08/2007
08/16/2007US20070190113 Agent for inhibiting postprandial increase in blood neutral fat level and foods containing the same
08/16/2007US20070190112 Treating neovascularization by placing bioerodible drug delivery system comprising an immunosuppressive agent and a bioerodible polymer (glycolic acid-lactic acid copolymer); sustained release
08/16/2007US20070190100 Engineering of material surfaces
08/16/2007US20070190060 Passive targeting of cytotoxic agents
08/16/2007US20070190026 Method Of Treatment Using Interferon-Tau
08/16/2007US20070190021 Poly(diallylamine)-based bile acid sequestrants
08/16/2007US20070190018 acetal resin or ketone polymer conjugate; drug covalently attached to polymer via succinamide linkages; the succinamidoester is oriented such that an ester is formed at the carrier side while the carboxyl forms amide bond with an amine-containing drug; glycine link; drug delivery; camptothecin CPT, Taxol
08/16/2007US20070189975 Hydrophilic matrix for delivery of active agent and product containing same
08/16/2007US20070189968 Gel composition for filling a breast milk duct prior to surgical excision of the duct or other breast tissue
08/16/2007US20070189963 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis
08/16/2007US20070189962 Mutated anti-cd22 antibodies and immunoconjugates
08/16/2007CA2641638A1 A direct cellular energy delivery system
08/16/2007CA2641588A1 Stabilized compositions of proteins having a free thiol moiety
08/16/2007CA2641070A1 Enzyme replacement therapy for treating lysosomal storage diseases
08/16/2007CA2638026A1 Bladder cancer treatment by using e09 and propylene glycol
08/16/2007CA2635797A1 Stable formulations, and methods of their preparation and use
08/15/2007EP1818123A1 Stabilized inorganic nanoparticle, stabilized inorganic nanoparticles, process for producing stabilized inorganic nanoparticle, and method of utilizing stabilized inorganic nanoparticle
08/15/2007EP1818064A2 Methods of treating skin to enhance therapeutic treatment thereof
08/15/2007EP1818062A1 An anti HSP90 antibody
08/15/2007EP1818051A1 Microgranules of morphine sulphate, preparation method and composition containing them
08/15/2007EP1818047A2 Oral administration form for difficulty soluble basic active ingredients
08/15/2007EP1818041A2 Pharmaceutical and/or cosmetic composition containing an organosiloxane and a phospholipid
08/15/2007EP1818029A2 Sequential drug delivery systems
08/15/2007EP1817348A1 Per-6-guanidino-, -aminoalkylamino-and -guanidino-alkylamino-cyclodextrins, methods of their synthesis and their use for the compaction of dna and interacellular delivery
08/15/2007EP1817347A1 Method of cross-linking hyaluronic acid with divinylsulfone
08/15/2007EP1817336A2 Auristatins having an aminobenzoic acid unit at the n terminus
08/15/2007EP1817065A2 Viscoelastic solutions containing sodium hyaluronate and hydroxypropylmethyl- cellulose, preparation and uses
08/15/2007EP1817059A2 Conjugates of 1,8-bis-naphthalimides with an antibody
08/15/2007EP1817058A2 Methods for improving liver clearance of xenobiotic substances in an animal
08/15/2007EP1817051A2 Pharmaceutical compositions comprising botulinum neurotoxin, a non ionic surfactant, sodium chloride and sucrose
08/15/2007EP1817043A1 Encapsulated bacteriophage formulation
08/15/2007EP1817035A1 Solid formulations of liquid biologically active agents
08/15/2007EP1636263B1 Pegylated soluble gp130-dimers useful as a medicament
08/15/2007EP1635852B1 Use of nail restructuring compositions for topical application in onychoschizia
08/15/2007EP1558763A4 Identification of diet-regulated disease-associated genes
08/15/2007EP1549295A4 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof
08/15/2007EP1542705B1 Anticoagulant composition
08/15/2007EP1471886B1 Method for increasing the water-solubility of lipophilic, active substances, production of highly concentrated aqueous compositions of said active substances, corresponding products and their use
08/15/2007EP1465676B1 Film-forming compositions and their uses
08/15/2007EP1363668B1 Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
08/15/2007EP1361856B1 Gel emulsions in the form of o/w emulsions having a hydrocolloid content
08/15/2007EP1357899B1 Oral itraconazole formulations and methods of making the same
08/15/2007EP1355588B1 Device for delivery of therepeutic agents
08/15/2007EP1343488B1 Treatment of statin side effects
08/15/2007EP1328288B1 Protein mixtures for wound healing
08/15/2007EP1294439B1 Shelf storage stable iontophoresis reservoir-electrode and iontophoretic system
08/15/2007EP1280552B1 Methods of treating skin cancer using compositions comprising an inhibitor of endothelin receptor b
08/15/2007EP1232251B1 Method of thrombolysis by local delivery of reversibly inactivated acidified plasmin
08/15/2007EP1222922B1 Method for stabilizing benzimidazole compounds
08/15/2007EP1198254B1 Carrier-drug conjugate
08/15/2007EP1108023B1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor
08/15/2007EP0784684B1 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES
08/15/2007EP0752874B1 Enhanced virus-mediated dna transfer
08/15/2007CN1331584C Emulsifier for highly liquid W/O emulsion
08/15/2007CN1331532C Botulinum toxin pharmaceutical compositions
08/15/2007CN1331477C Medical nano-carbon tube composition, preparation method and its application
08/15/2007CN1331472C Quetiapingranulater
08/15/2007CN1331467C Ursine fat injection emulsion, and its prepn. method
08/15/2007CN1331463C Method for chemo-prevention of prostate cancer
08/15/2007CN101018798A Crystalline maltitol powder less prone to consolidation and method for production thereof
08/15/2007CN101018793A Phosphorylated polyphenols as colour-stable agents
08/15/2007CN101018560A Permucosal composition and method of improving permucosal absorption
08/15/2007CN101018543A Cefdinir oral suspension
08/15/2007CN101018542A Testosterone gels comprising propylene glycol as penetration enhancer
08/15/2007CN101016345A Poly carbophil non-crosslinking chitosan and application thereof
08/15/2007CN101016312A Method of preparing powder phosphatide and lecithin for medicine and injection from soybean oil residue
08/15/2007CN101015699A Polyethylene glycol-phosphatidyl ethanolamine polymer or medicinal acid addition salt and application thereof in pharmacy
08/15/2007CN101015698A Medicament using rare earth transferring complex compound as vector
08/15/2007CN101015697A A local drug-release system and a method of the manufacture thereof
08/15/2007CN101015696A Antisense oligonucleotide-carbon nanotube medicament vector
08/15/2007CN101015659A Health-care food for reducing blood sugar on the assistant role and its preparing process
08/15/2007CN101015640A Dragon's blood dropping pill and its preparing process
08/15/2007CN101015630A Traditional Chinese medicine soft capsule and its preparing process and quality controlling means
08/15/2007CN101015605A Health-care food for improving sleeping and its preparing process
08/15/2007CN101015573A Patrinai villosa dropping pill and its preparing process
08/15/2007CN101015571A Chinese caterpillar fungus polysaccharide buccal tablets and its preparing process
08/15/2007CN101015565A Vaginal abluent
08/15/2007CN101015564A Exterior-applied pigmentum for treating otitis media suppurativa and its preparing method
08/15/2007CN101015563A Intravenous injection microemulsion preparation of teniposide
08/15/2007CN101015562A DiAo Xinxuekang soft capsule and preparation process and use thereof
08/15/2007CN101015560A Compound suladime sulfadiazine sodium injection and its preparation
08/15/2007CN101015559A Instant gelling agent for treating allergic rhinitis
08/15/2007CN101015558A Preparation of superfine prednisolone powder
08/15/2007CN101015550A Preparing method of triptolide molecule microcapsule
08/15/2007CN101015548A Compound paclitaxel preparation containing phospholipid dispersant and its preparation method
08/15/2007CN101015547A Docetaxel liposome formulation and preparation method thereof
08/15/2007CN101015542A Compound paracetamol injection for livestock and process for preparing same
08/15/2007CN101015541A Diacetyl rhein dropping pills and its preparing process
08/15/2007CN101015538A Medicinal composition of total capsicine compounds and beta-cyclodextrin or derivative of beta-cyclodextrin
08/15/2007CN101015537A Preparation method of sodium iron chlorophyllin-ethyl cellulose microcapsule
08/15/2007CN101015535A Sustained release preparation of perhexiline
08/15/2007CN101015534A Sustained release preparation of phenprobamate
08/15/2007CN101015533A Sustained release preparation of norfloxacin
08/15/2007CN101015532A Sustained release preparation of phenytoin sodiumslow release
08/15/2007CN101015531A Sustained release preparation of dibazole
08/15/2007CN101015530A Sustained release preparation of doxepin
08/15/2007CN101015529A Sustained release preparation of amoxillin and dicloxacillin
08/15/2007CN101015528A Sustained release preparation of amoxillin and flucloxacillin
08/15/2007CN101015527A Dropping pills preparation
08/15/2007CN101015526A Topotecan liposome and preparation method therefor
1 ... 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 ... 1712